London, April 7
The European Medicines Agency will announce the conclusions of its investigation into the doable connection between AstraZeneca’s coronavirus vaccine and uncommon blood clots later Wednesday.
On Tuesday, a senior EMA official stated there was a causal hyperlink between the AstraZeneca vaccine and the uncommon blood clots which were seen in dozens of individuals worldwide, among the many tens of tens of millions who’ve obtained at the very least one dose.
In feedback to Rome’s Il Messaggero newspaper, Marco Cavaleri, head of well being threats and vaccine technique on the Amsterdam-based company, stated “it is becoming more and more difficult to affirm that there isn’t a cause-and-effect relationship between AstraZeneca vaccines and the very rare cases of blood clots associated with a low level of platelets”.
But Cavaleri acknowledged the company had not but discovered how precisely the vaccine is perhaps inflicting these uncommon uncomfortable side effects. AP